U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07513649) titled 'A Study to Evaluate the Bioequivalence of DA-5230 Compared to DA-5230-R' on March 31.
Brief Summary: A study to evaluate the bioequivalence of DA-5230 compared to DA-5230-R
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Healthy Adult Participants
Intervention:
DRUG: DA-5230
Test drug
DRUG: DA-5230-R
Reference drug
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Dong-A ST Co., Ltd.
Disclaimer: Curated by HT Syndication....